Amsterdam – CFI is pleased to announce it acted as the exclusive corporate finance advisor to the shareholders of Performation Healthcare Intelligence (‘Performation’ or the ‘Company’), in its sale to funds managed by Gilde Healthcare.
Performation Healthcare Intelligence is a provider of healthcare specific business intelligence solutions to monitor costs, processes and quality. The company supports clients in taking well-informed decisions that contribute to the delivery of high quality and effective care. With over a hundred consultants and business intelligence experts, Performation is a leading player in the Dutch healthcare techology market.
Gilde Healthcare is a specialised European healthcare investor managing two business lines: a private equity fund aimed at lower mid-market buy-outs and a venture & growth fund. Gilde Healthcare’s private equity fund has offices in Utrecht and Frankfurt and invests in profitable European healthcare services companies with a focus on the Benelux and DACH region. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare’s venture & growth fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are based in Europe and North America. Since 2001 Gilde Healthcare has raised €1 billion for its specialised funds.
CFI Netherlands initiated discussions and negotiations with a select range of strategic and financial buyers in a process that ultimately resulted in a successful transaction with Gilde Healthcare, which closed on 2 February 2018.
have been sold to a consortium including
RedGazelle Group sells Big Data Republic, a big data science and big data engineering specialist, and JDriven and JCore, a Java/JVM enterprise software business, through a Buy-In Management Buyout transaction backed by a private equity consortium comprising Navitas Capital and Quadrum Capital